Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Ohya

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 28, 2025
Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)Yusuke Ohya, Atsushi Sakima, Hisatomi Arima, et al.
Journal of Diabetes Investigation|May 22, 2026
Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D-PATH study)Yuki Nakatani, Nobuyuki Banba, Shoya Ono, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2013
Long-term treatment with san'o-shashin-to, a kampo medicine, markedly ameliorates cardiac ischemia-reperfusion injury in ovariectomized rats via the redox-dependent mechanismMayuko Sakanashi, Toshihiro Matsuzaki, Katsuhiko Noguchi, et al.
European Journal of Preventive Cardiology|February 5, 2026
Effects of inpatient and outpatient cardiac rehabilitation on the 5-year prognosis in patients with acute myocardial infarctionYasunori Suematsu, Akira Minei, Yoko Sumita, et al.
European Journal of Preventive Cardiology|March 21, 2025
Effects of inpatient and outpatient cardiac rehabilitation on the 5-year prognosis in patients with acute myocardial infarctionYasunori Suematsu, Akira Minei, Yoko Sumita, et al.
Journal of Cardiology|March 24, 2016
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemiaSunao Kojima, Kunihiko Matsui, Hisao Ogawa, et al.
International Journal of Cardiology|February 22, 2022
Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary interventionKaoru Akimaru, Masashi Iwabuchi, Akio Ishida, et al.
Clinical Pharmacology and Therapeutics|February 23, 2024
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled TrialMasahiro Sugawara, Sunao Kojima, Ichiro Hisatome, et al.
Circulation Reports|November 21, 2022
Study Design of the Japanese Association of Cardiac Rehabilitation Registry (J-CARRY) - Protocol for a Prospective, Multicenter, Open RegistryKeisuke Kida, Miho Nishitani-Yokoyama, Kazunori Shimada, et al.
Cardiovascular Drugs and Therapy|June 1, 2022
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled StudySunao Kojima, Kazuaki Uchiyama, Naoto Yokota, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 28, 2025
Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)Yusuke Ohya, Atsushi Sakima, Hisatomi Arima, et al.
Journal of Diabetes Investigation|May 22, 2026
Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D-PATH study)Yuki Nakatani, Nobuyuki Banba, Shoya Ono, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2013
Long-term treatment with san'o-shashin-to, a kampo medicine, markedly ameliorates cardiac ischemia-reperfusion injury in ovariectomized rats via the redox-dependent mechanismMayuko Sakanashi, Toshihiro Matsuzaki, Katsuhiko Noguchi, et al.
European Journal of Preventive Cardiology|February 5, 2026
Effects of inpatient and outpatient cardiac rehabilitation on the 5-year prognosis in patients with acute myocardial infarctionYasunori Suematsu, Akira Minei, Yoko Sumita, et al.
European Journal of Preventive Cardiology|March 21, 2025
Effects of inpatient and outpatient cardiac rehabilitation on the 5-year prognosis in patients with acute myocardial infarctionYasunori Suematsu, Akira Minei, Yoko Sumita, et al.
Journal of Cardiology|March 24, 2016
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemiaSunao Kojima, Kunihiko Matsui, Hisao Ogawa, et al.
International Journal of Cardiology|February 22, 2022
Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary interventionKaoru Akimaru, Masashi Iwabuchi, Akio Ishida, et al.
Clinical Pharmacology and Therapeutics|February 23, 2024
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled TrialMasahiro Sugawara, Sunao Kojima, Ichiro Hisatome, et al.
Circulation Reports|November 21, 2022
Study Design of the Japanese Association of Cardiac Rehabilitation Registry (J-CARRY) - Protocol for a Prospective, Multicenter, Open RegistryKeisuke Kida, Miho Nishitani-Yokoyama, Kazunori Shimada, et al.
Cardiovascular Drugs and Therapy|June 1, 2022
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled StudySunao Kojima, Kazuaki Uchiyama, Naoto Yokota, et al.
Pageof 16